Hiroaki Kiyokawa

9.5k total citations · 1 hit paper
117 papers, 7.8k citations indexed

About

Hiroaki Kiyokawa is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Hiroaki Kiyokawa has authored 117 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 61 papers in Oncology and 22 papers in Cell Biology. Recurrent topics in Hiroaki Kiyokawa's work include Cancer-related Molecular Pathways (50 papers), Ubiquitin and proteasome pathways (28 papers) and Epigenetics and DNA Methylation (21 papers). Hiroaki Kiyokawa is often cited by papers focused on Cancer-related Molecular Pathways (50 papers), Ubiquitin and proteasome pathways (28 papers) and Epigenetics and DNA Methylation (21 papers). Hiroaki Kiyokawa collaborates with scholars based in United States, Japan and China. Hiroaki Kiyokawa's co-authors include Andrew Koff, Dipankar Ray, Philipp Kaldis, Rhonda D. Kineman, Masao Ono, Eric S. Hoffman, Adrian Hayday, Katia Manova‐Todorova, Lawrence A. Frohman and Eiman Aleem and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Hiroaki Kiyokawa

112 papers receiving 7.7k citations

Hit Papers

Enhanced Growth of Mice Lacking the Cyclin-Dependent Kina... 1996 2026 2006 2016 1996 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
    1996 1.1k citations Hiroaki Kiyokawa, Andrew Koff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Kiyokawa United States 47 5.5k 3.5k 1.2k 958 820 117 7.8k
W. J. Pledger United States 42 5.0k 0.9× 2.5k 0.7× 1.2k 1.0× 1.0k 1.1× 589 0.7× 114 7.9k
Ada Sacchi Italy 55 5.8k 1.0× 3.7k 1.1× 1.2k 1.0× 1.5k 1.6× 612 0.7× 162 8.4k
Monica Nistér Sweden 50 5.5k 1.0× 2.4k 0.7× 796 0.7× 1.9k 1.9× 521 0.6× 160 9.1k
Pierre Dubus France 42 5.3k 1.0× 4.0k 1.1× 1.7k 1.4× 1.2k 1.2× 637 0.8× 163 9.7k
Rakesh Kumar United States 47 4.6k 0.8× 2.2k 0.6× 816 0.7× 1.2k 1.3× 1.7k 2.0× 160 7.1k
Francisco Portillo Spain 39 6.6k 1.2× 3.0k 0.9× 1.1k 1.0× 1.5k 1.6× 558 0.7× 85 8.7k
Sagrario Ortega Spain 45 6.9k 1.2× 3.0k 0.9× 1.5k 1.2× 878 0.9× 831 1.0× 88 9.6k
Claudio J. Conti United States 44 3.6k 0.7× 2.4k 0.7× 800 0.7× 1.3k 1.4× 785 1.0× 134 6.0k
Elena Sancho Spain 23 6.7k 1.2× 4.7k 1.3× 1.2k 1.0× 1.8k 1.9× 1.5k 1.8× 28 10.3k
Lars Rönnstrand Sweden 54 5.9k 1.1× 2.0k 0.6× 1.2k 1.0× 957 1.0× 468 0.6× 173 10.2k

Countries citing papers authored by Hiroaki Kiyokawa

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kiyokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kiyokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kiyokawa more than expected).

Fields of papers citing papers by Hiroaki Kiyokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kiyokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kiyokawa. The network helps show where Hiroaki Kiyokawa may publish in the future.

Co-authorship network of co-authors of Hiroaki Kiyokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kiyokawa. A scholar is included among the top collaborators of Hiroaki Kiyokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kiyokawa. Hiroaki Kiyokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Geng, Jing Zhang, Xiaoyu Wang, et al.. (2025). Engineering a cell-based orthogonal ubiquitin transfer cascade for profiling the substrates of RBR E3 Parkin. iScience. 28(7). 112913–112913.
3.
Chen, Geng, Yiyang Wang, Tatiana A. Chernova, et al.. (2023). Profiling and verifying the substrates of E3 ubiquitin ligase Rsp5 in yeast cells. STAR Protocols. 4(3). 102489–102489.
4.
Bai, Feng, Ho Lam Chan, Matthew D. Smith, Hiroaki Kiyokawa, & Xin‐Hai Pei. (2014). p19Ink4d Is a Tumor Suppressor and Controls Pituitary Anterior Lobe Cell Proliferation. Molecular and Cellular Biology. 34(12). 2121–2134. 16 indexed citations
5.
Ray, Dipankar, Yasuhisa Terao, Konstantin Christov, Philipp Kaldis, & Hiroaki Kiyokawa. (2011). Cdk2-Null Mice Are Resistant to ErbB-2-Induced Mammary Tumorigenesis. Neoplasia. 13(5). 439–444. 23 indexed citations
6.
Liu, Li, Barbara R. Schwartz, Yoshiaki Tsubota, et al.. (2008). Cyclin-Dependent Kinase Inhibitors Block Leukocyte Adhesion and Migration. The Journal of Immunology. 180(3). 1808–1817. 14 indexed citations
7.
Ray, Dipankar & Hiroaki Kiyokawa. (2008). CDC25A Phosphatase: a Rate-Limiting Oncogene That Determines Genomic Stability. Cancer Research. 68(5). 1251–1253. 66 indexed citations
8.
Ray, Dipankar, Yasuhisa Terao, Francesco J. DeMayo, et al.. (2007). Deregulated CDC25A Expression Promotes Mammary Tumorigenesis with Genomic Instability. Cancer Research. 67(3). 984–991. 55 indexed citations
9.
Ray, Dipankar, Yasuhisa Terao, Hiroyuki Hirai, et al.. (2007). Hemizygous Disruption of Cdc25A Inhibits Cellular Transformation and Mammary Tumorigenesis in Mice. Cancer Research. 67(14). 6605–6611. 63 indexed citations
10.
Ray, Dipankar & Hiroaki Kiyokawa. (2007). CDC25A Levels Determine the Balance of Proliferation and Checkpoint Response. Cell Cycle. 6(24). 3039–3042. 27 indexed citations
11.
Marval, Paula L. Miliani de, Everardo Macías, Robert J. Rounbehler, et al.. (2004). Lack of Cyclin-Dependent Kinase 4 Inhibits c- myc Tumorigenic Activities in Epithelial Tissues. Molecular and Cellular Biology. 24(17). 7538–7547. 85 indexed citations
12.
Jirawatnotai, Siwanon, David S. Moons, Carlos Stocco, et al.. (2003). The Cyclin-dependent Kinase Inhibitors p27Kip1 and p21Cip1 Cooperate to Restrict Proliferative Life Span in Differentiating Ovarian Cells. Journal of Biological Chemistry. 278(19). 17021–17027. 53 indexed citations
13.
Rodríguez‐Puebla, Marcelo L., Paula L. Miliani de Marval, Margaret LaCava, et al.. (2002). cdk4 Deficiency Inhibits Skin Tumor Development but Does Not Affect Normal Keratinocyte Proliferation. American Journal Of Pathology. 161(2). 405–411. 65 indexed citations
14.
Tsutsui, Tateki, et al.. (1999). Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 Kip1 Activity. Molecular and Cellular Biology. 19(10). 7011–7019. 328 indexed citations
15.
Beumer, Tim L., Hiroaki Kiyokawa, Hermien L. Roepers‐Gajadien, et al.. (1999). Regulatory Role of p27kip1 in the Mouse and Human Testis*. Endocrinology. 140(4). 1834–1840. 82 indexed citations
16.
Missero, Caterina, Ferdinando Di Cunto, Hiroaki Kiyokawa, Andrew Koff, & G. Paolo Dotto. (1996). The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.. Genes & Development. 10(23). 3065–3075. 271 indexed citations
17.
Kiyokawa, Hiroaki, Victoria M. Richon, Richard A. Rifkind, & Paul A. Marks. (1994). Suppression of Cyclin-Dependent Kinase 4 during Induced Differentiation of Erythroleukemia Cells. Molecular and Cellular Biology. 14(11). 7195–7203. 24 indexed citations
18.
Kiyokawa, Hiroaki, et al.. (1993). Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.. Proceedings of the National Academy of Sciences. 90(14). 6746–6750. 41 indexed citations
19.
Kiyokawa, Hiroaki, Norio Kôno, Tomoya Hamaguchi, et al.. (1989). Hyperinsulinemia due to Impaired Insulin Clearance Associated with Fasting Hypoglycemia and Postprandial Hyperglycemia: An Analysis of a Patient with Antiinsulin Receptor Antibodies*. The Journal of Clinical Endocrinology & Metabolism. 69(3). 616–621. 12 indexed citations
20.
Mineo, Ikuo, Norio Kôno, Naoko Hara, et al.. (1987). Myogenic Hyperuricemia. New England Journal of Medicine. 317(2). 75–80. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. J. Pledger Breakdown of academic impact, for papers by Ada Sacchi Breakdown of academic impact, for papers by Monica Nistér Breakdown of academic impact, for papers by Pierre Dubus Breakdown of academic impact, for papers by Rakesh Kumar Breakdown of academic impact, for papers by Francisco Portillo Breakdown of academic impact, for papers by Sagrario Ortega Breakdown of academic impact, for papers by Claudio J. Conti Breakdown of academic impact, for papers by Elena Sancho Breakdown of academic impact, for papers by Lars Rönnstrand
Rankless by CCL
2026